Nutrition and cognitive impairment in the elderly

British Journal of Nutrition

Volumn 86, Issue 3, 2001, Pages 313-321

  Gonzalez Gross M ^a   Marcos, Ascensión ^b   Pietrzik, Klaus ^a  

^a CSIC   (Spain)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer's disease; Dementia; Elderly; Homocysteine; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; ESTROGEN; FOLIC ACID; HOMOCYSTEINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NOOTROPIC AGENT; PYRIDOXINE; UBIQUINONE;

AGED; AGING; ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DIET THERAPY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; ELDERLY CARE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; NUTRITION; NUTRITIONAL DEFICIENCY; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; ONSET AGE; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PUBLIC HEALTH; QUALITY OF LIFE; REVIEW; RISK FACTOR;

EID: 0034814629     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/bjn2001388     Document Type: Review

References (102)

1. Personality and psychopathology in late life
2. Positioning of the ADA: Nutrition, aging, and the continuum of care
3. Plasma homocysteine, brain MR lesions, and cognitive functions in elderly diabetic patients
4. Cobalamin levels are not reduced in Alzheimer's disease: Results from a population based study
5. Vitamin E and other antioxidants in neuroprotection
6. Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection
7. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people
8. The role of estrogen in the treatment and prevention of dementia: Introduction
9. Hormones and the aging brain
10. Oestrogens and Alzheimer's disease
11. Relationships between cholesterol, apolipoprotein E polymorphism and dementia: A cross-sectional analysis from the PAQUID study
12. Folate-responsive neurological and mental disorders: Report of 16 cases. Neuropsychological correlates of computerized transaxial tomography and radionuclide cisternography in folic acid deficiencies
13. 12, and neuropsychiatric disorders
14. Lowering of homocysteine concentrations in elderly men and women
15. Documentation and evaluation of cognitive impairment in elderly primary care patients
16. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities
17. Current concepts in the pathogenesis of Alzheimer's disease
18. Factors associated with cognitive impairment among older Italian inpatients
19. Graying of the immune system. Can nutrient supplements improve immunity in the elderly?
20. Nutrition of the elderly
21. ACE, MTHFR, factor V Leiden, and ApoE polymorphisms in patients with vascular and Alzheimer's dementia
22. Criteria for the clinical diagnosis of ischemic vascular dementia prepared by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
23. 12, and serum homocysteine levels in confirmed Alzheimer's disease
24. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort
25. Advances and challenges in the prevention and treatment of Alzheimer's disease
26. Combination therapy for early Alzheimer's disease: What are we waiting for?
27. Olfactory capacities in aging and Alzheimer's disease: Psychophysical and anatomic considerations
28. Assessing problem feeding behaviors in mid-stage Alzheimer's disease
29. Effects of chronic hypertension on cognitive functioning
30. 12 concentrations in psychiatric patients
31. Homocysteine in cerebal macroangiography and microangiopathy
32. Abnormal amino acid metabolism in patients with early stage Alzheimer dementia
33. Brain serotonin content: Physiological regulation by plasma neutral amino acids
34. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician
35. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease
36. Variables associated with cognitive function in elderly California Seventh-day Adventist
37. Endogenous Alzheimer's brain factor and oxidized glutathione inhibit antagonist binding to the muscarinic receptor
38. Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects
39. Cognitive impairment and mortality in a cohort of elderly people
40. Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders
41. Value of Hodkinson's test for detecting dementia and mild cognitive impairment in epidemiological surveys
42. Association between nutritional status and cognitive functioning in a healthy elderly population
43. Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease
44. Nutrition and dementia
45. Mental health: Minimental state examination and geriatric depression score of elderly europeans in the SENECA study of 1993
46. Dietary patterns and cognitive function in elderly men in Finland, Italy and the Netherlands
47. A comparison of ADAS and EEG in the discrimination of patients with dementia of the Alzheimer type from healthy controls
48. Dietary antioxidants and cognitive function in a population-based sample of elder people
49. Is metabolic evidence for vitamin B-12 and folic acid deficiency more frequent in elderly patients with Alzheimer's disease?
50. Polyunsaturated fatty acids, antioxidants, and cognitive functions in very old men
51. Folic acids: Supplemental forms and therapeutic applications
52. Current pharmacotherapies for Alzheimer's disease
53. Folic acid nutrition and older adults: Challenges and opportunities
54. Association of sociodemographic factors with barriers reported by patients receiving nutrition counselling as part of cardiac rehabilitation
55. Overview of incidence studies of dementia conducted in Europe
56. Antioxidants and dementia
57. Estimated folic acid intakes: Data updated to reflect food fortification, increased bioavailability, and dietary supplement use
58. Age-associated changes in the content and fatty acids composition of brain glycerophospholipids
59. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients
60. Total serum homocysteine in senile dementia of Alzheimer type
61. Refusal to eat in the elderly
62. Oxidative alterations in Alzheimer's disease
63. Mental status examination for organic mental syndrome in the elderly patient
64. Clinical efficacy of Ginkgo biloba special extract EGb761 in dementia of the Alzheimer type
65. Homocysteine and Alzheimer's disease
66. Low-density lipoprotein cholesterol and the risk of dementia with stroke
67. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease
68. Hyperhomocysteinaemia - A common finding in a psychogeriatric population
69. Eating problems in severely demented patients: Issues and ethical dilemmas
70. Cohort study of vitamin C intake and cognitive impairment
71. Role of homocysteine in age-related vascular and non-vascular diseases
72. Folic acid in preventive medicine: A new role in cardiovascular disease, neural tube defects and cancer
73. Current status of antioxidant therapy for Alzheimer's disease
74. The association between apoE and dementia does not seem to be mediated by vascular factors
75. Stroke and the aging of the brain and the arteries
76. The role of the polymorphic genes apolipoprotein E and methylene-tetrahydrofolic acid reductase in the development of dementia of the Alzheimer type
77. Relations of vitamin B12, vitamin B6, and homocysteine to cognitive performance in the Normative Aging Study
78. Low plasma vitamin C in Alzheimer patients despite an adequate diet
79. Nutritional factors in physical and cognitive functions of elderly people
80. Free radicals in Alzheimer's dementia: Currently available therapeutic strategies
81. CAMEX: A standardised instrument for the diagnosis of medical disorder in the elderly with special reference to the early detection of dementia
82. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
83. Plasma antioxidants and cognitive performance in middle-aged and older adults: Results of the Austrian Stroke Prevention Study
84. New therapeutic approaches to cognitive impairment
85. Alzheimer's disease: Genotypes, phenotype, and treatments
86. Promising agents for treating Alzheimer's disease
87. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia
88. Fifteen-year longitudinal study of blood pressure and dementia
89. Neuroimaging for diagnosis of dementia
90. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun Study
91. High monounsaturated fatty acids intake protects against age-related cognitive decline
92. An update of vitamin B12 metabolism and deficiency states
93. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects
94. Analysis of alpha-1 antichymotrypsin, persenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolic acid reductase loci as candidates for dementia
95. La dieta Mediterránea
96. Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation
97. Apolipoprotein E genotype and lipid and lipoprotein levels in dementia
98. Diet therapy in gout
99. World Health Day will focus on ageing